Listed

Nephros Inc: Form 10-Q for the period ended Sep 30, 2017

Filed with the SEC on Nov 9, 2017 and accepted by EDGAR at Nov 9, 2017, 07:01 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Gross profit3 months2017-07-01 to 2017-09-30$532.0kus-gaap:GrossProfit
Gross profit9 months2017-01-01 to 2017-09-30$1.5mus-gaap:GrossProfit
Selling, general and administrative3 months2017-07-01 to 2017-09-30$753.0kus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2017-01-01 to 2017-09-30$2.4mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2017-07-01 to 2017-09-30−$518.0kus-gaap:OperatingIncomeLoss
Operating income9 months2017-01-01 to 2017-09-30−$1.8mus-gaap:OperatingIncomeLoss
Interest expense3 months2017-07-01 to 2017-09-30$88.0kus-gaap:InterestExpense
Interest expense9 months2017-01-01 to 2017-09-30$218.0kus-gaap:InterestExpense
Net income3 months2017-07-01 to 2017-09-30−$632.0kus-gaap:NetIncomeLoss
Net income9 months2017-01-01 to 2017-09-30−$2.1mus-gaap:NetIncomeLoss
Diluted EPS3 months2017-07-01 to 2017-09-30−$0.01us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2017-01-01 to 2017-09-30−$0.04us-gaap:EarningsPerShareBasicAndDiluted
Cash and equivalentsAt period end2017-09-30$150.0kus-gaap:Cash
Current assetsAt period end2017-09-30$1.6mus-gaap:AssetsCurrent
Total assetsAt period end2017-09-30$2.8mus-gaap:Assets
Current liabilitiesAt period end2017-09-30$1.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-09-30$2.6mus-gaap:Liabilities
Shareholders' equityAt period end2017-09-30$265.0kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493152-17-012641. Last ingested by Listed: Nov 13, 2026, 16:20 ET. Listed shows no prices and gives no investment advice.